16th April, 2021
The central government has allowed Mumbai-based Hafkine Bio-Pharmaceutical to make Bharat Biotech's anti-corona vaccine Covaxin. According to information received from the Chief Minister's Office (CMO) official, Maharashtra (Maharashtra) Chief Minister Uddhav Thackeray had earlier requested the Center to allow the Hafkin Institute to produce covaxin, a company currently based in Hyderabad. Made in Pune by Bharat Biotech.
In this regard, Renu Swaroop, Secretary of, Central Science and Technology Department had sent a letter of approval to Maharashtra Chief Secretary Sitaram Kunte. “Swaroop informed the state government that the Center has approved Hafakin Bio-Pharmaceutical Corporation Limited for covaxin production. These decisions have been taken after the approval given by the experts.
126 million vaccine production target
Chief Minister Uddhav Thackeray had said that Hafkine Bio-Pharmaceutical should be allowed to transfer technology by the ICMR to the manufacture of coronavirus vaccine under "Mission Covid Security". It can be started with firm fill and finish operations. The firm aims to manufacture 126 minions of the vaccine. Hafkin has developed many vaccines before.
In January, Haffkine Bio-Pharmaceutical sought permission from the ICMR (Indian Council of Medical Research) to transfer the technology from Bharat Biotech, which has developed the first indigenous Covid-19 vaccine in the country. Please tell that Hafkin is a public sector undertaking owned by the state government. Hafkin has also developed a variety of vaccines in the past, including Anti-Rabies Serum, Anti Venom Serum, Oral Polio Vaccine, etc.